PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Short Interest Down 21.5% in September

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) was the target of a significant decline in short interest in September. As of September 15th, there was short interest totalling 7,300 shares, a decline of 21.5% from the August 31st total of 9,300 shares. Based on an average daily trading volume, of 65,300 shares, the days-to-cover ratio is currently 0.1 days.

PreveCeutical Medical Trading Down 0.8 %

Shares of OTCMKTS PRVCF traded down $0.00 during trading on Friday, reaching $0.01. The stock had a trading volume of 38,533 shares, compared to its average volume of 51,742. PreveCeutical Medical has a fifty-two week low of $0.01 and a fifty-two week high of $0.02. The business’s 50-day moving average price is $0.01 and its 200-day moving average price is $0.02.

PreveCeutical Medical Company Profile

PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity.